Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study

keywords

  • GLIOBLASTOMA-MULTIFORME
  • Life Sciences & Biomedicine
  • PACLITAXEL
  • Science & Technology

Digital Object Identifier (DOI)

end page

  • 3656

volume

  • 24

issue

  • 22